The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act

Johanna Catherine Maclean, Brendan Saloner

NBER Working Paper No. 23342
Issued in April 2017, Revised in September 2017

---- Acknowledgments ----

We thank Ioana Popovici, Douglas Webber, and Laura Wherry for helpful comments, and Steven Hill for data assistance. Brendan Saloner gratefully acknowledges funding from the National Institute on Drug Abuse (K01 DA042139). All errors are our own. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.

return to bibliography page